# Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome.

> **NCT03919266** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 72 (actual)

## Conditions studied

- Acute Chest Syndrome
- Sickle Cell Disease

## Interventions

- **PROCEDURE:** Intervention: Combined use of a respiratory broad panel multiplex PCR and procalcitonin
- **PROCEDURE:** Control: usual antibiotic treatment

## Key facts

- **NCT ID:** NCT03919266
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-02
- **Primary completion:** 2022-10-10
- **Final completion:** 2022-10-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919266, "Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03919266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*